Weight Loss and Diabetes Drugs

Key Highlights: A New Hope for Obesity and Diabetes Obesity and type 2 diabetes (T2D) are global health crises, affecting 1 billion and 537 million adults worldwide, respectively . Orforglipron, an oral GLP-1 receptor agonist developed by Eli Lilly, offers a groundbreaking solution. Unlike injectable alternatives, this pill-based medication simplifies treatment, making it more accessible and user-friendly. This blog … Read more